Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

AZ’s Soriot upbeat on firm’s prospects

Says pharma company can return to growth by 2017

Sanofi reception

Sanofi forms antibiotic research partnership

Will team up with Germany’s Fraunhofer-Gesellschaft to develop naturally-derived substances

- PMLiVE

FDA panel backs Merck’s vorapaxar

On course for US approval to reduce vascular events in certain patients

ABPI London offices

ABPI Code updates come into effect

UK pharma trade body puts 2014 changes into action

- PMLiVE

Endo opts for Ogilvy PR

Agency will provide PR support for Endo’s men’s health and pain management business

- PMLiVE

Joint MDs for Red Health

Two in-house promotions fill the gap left by Jennifer Garratt

- PMLiVE

IMI appoints new chair of scientific committee

Portugal’s Maria Beatriz da Silva Lima to join EC’s collaborative research group

Bayer symbol

Bayer and Regeneron to develop second wet AMD therapy

Will collaborate on drug to be used in combination with Eylea

- PMLiVE

FDA panel backs Chelsea’s Northera for rare disease

Committee votes in favour of treatment for low blood pressure

- PMLiVE

FDA sets standard review for Gilead’s idelalisib in NHL

Comes despite accelerated review for drug’s use in chronic lymphocytic leukaemia

- PMLiVE

Another Ranbaxy plant falls foul of FDA

Indian company violates Good Manufacturing Practice

- PMLiVE

Europe approaches mHealth tipping point

Drop the industry shorthand and a significant proportion of consumers are now open to mobile health tools

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links